{
    "nctId": "NCT02590822",
    "officialTitle": "Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction. The Diastolic Study",
    "inclusionCriteria": "* Capacity to provide informed consent before any trial-related activities\n* Established T2DM (\u22653months)\n* HbA1c \u2264 9% if on triple therapy or \u2264 10% on diet \\& exercise or monotherapy or dual therapy\n* Current glucose lowering therapy either mono, dual or triple of any combination of metformin, sulphonylurea, DPP-IV inhibitor, GLP-1 therapy or an SGLT2 +/- diet and exercise\n* Poorly managed diet controlled diabetes (with HbA1c \\> 6.5% , not currently taking any glucose lowering therapy, meeting BMI inclusion range)\n* Body mass index \\> 30Kg/m2 or \\> 27.5 Kg/m2 (South Asian),\n* Diagnosis of T2DM before the age of 60 years of age\n* Age \u226518 and \u2264 65 years\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "* \u2022 Diabetes duration \\>12 years\n* Currently taking more than three glucose lowering therapies\n* Weight-loss of \\>5kg in the preceding 6 months\n* Stage 4 or 5 chronic kidney disease (eGFR\\< 30ml/min/1.73m2),\n* Current therapy with Insulin, thiazolidinediones, steroids or atypical antipsychotic medication\n* Untreated thyroid disease\n* Known macrovascular disease including coronary artery disease, stroke/TIA or peripheral vascular disease\n* Presence of arrhythmia (including atrial fibrillation, atrial flutter, or 2nd or 3rd degree atrioventricular block)\n* Known heart failure\n* Other clinically relevant heart disease\n* Inability to exercise or undertake a MRP\n* Absolute contraindication to CMR\n* Cardiovascular symptoms (angina, limiting dyspnoea during normal physical activity)\n* Inflammatory condition e.g. Connective tissue disorder, Rheumatoid arthritis"
}